News / Trade tension and tariffs force multinationals to eye China-centric supply chains

Photo 269220610 | Astrazeneca China © RobertWei | Dreamstime.com

With the US-China tariff war showing every sign of worsening, multinational firms are considering building independent supply chains for the US and China.

Leading pharmaceutical company AstraZeneca has announced plans to establish manufacturing plants in China to serve the region exclusively.

For China-focused forwarders, the news represents a beacon of hope that the logistics industry may be shielded from the worst of the tariff and tension fallout.

A spokesperson from Dimerco told The Loadstar the move by AstraZeneca demonstrated companies’ faith in China’s self-sufficient ...